The effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells

Su,Yan; Guan,Xiao-Qin; Liu,Feng-Qiu; Wang,Ya-Lan

doi:10.3892/ijmm.2014.1819

The effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells

Authors:
- Yan Su
- Xiao-Qin Guan
- Feng-Qiu Liu
- Ya-Lan Wang
View Affiliations

Affiliations: Molecular Medicine and Cancer Research Center, Department of Pathology, Chongqing Medical University, Chongqing, P.R. China
Published online on: June 24, 2014 https://doi.org/10.3892/ijmm.2014.1819
Pages: 842-848

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effects of meta-iodobenzylguanidine (MIBG) on the invasive properties of hepatocellular carcinoma (HCC) cells and examine whether these effects are due to the ability of MIBG to inhibit arginine-specific mono-ADP-ribosylation. Samples from patients with HCC were divided into 2 groups, a metastatic group and a non-metastatic group. Immunohistochemistry and RT-PCR were used to detect the protein and mRNA expression of arginine-specific adenosine diphosphate-ribosyltransferase 1 (ART1) and integrin α7 in the HCC tissues. In addition, the expression of ART1 was measured in HepG2 HCC cells by immunofluorescence. The inhibition of the metastasis of HepG2 cells by MIBG at various concentrations was measured by MTT assay. In addition, the effects of MIBG on HepG2 cell metastasis were measured using a scratch wound assay and a transwell invasion assay. Western blot analysis was used to detect the protein expression of ART1, integrin α7, focal adhesion kinase (FAK), phosphatidylinositol 3-kinase (PI3K) and urokinase-type plasminogen activator (uPA) in the HepG2 cells. The mRNA and protein levels of ART1 and integrin α7 were higher in the metastatic HCC samples than in the non-metastatic HCC samples. ART1 expression was detected in the HepG2 cells. The half maximal inhibition concentration (IC50) of MIBG in the HepG2 cells was 200 µmol/l (P<0.05). Within a certain dose range, MIBG exerted inhibitory effects on HepG2 cell migration in a dose-dependent manner. Treatment with MIBG significantly inhibited the migration and invasion of the HepG2 cells relative to the control cells (P<0.05) and reduced the protein expression of ART1, integrin α7, FAK, PI3K and uPA (P<0.05). Our data demonstrate that ART1 and integrin α7 may be involved in the invasive and metastatic properties of HCC cells. MIBG inhibited the migration and invasion of HepG2 cells, possibly through the inhibition of arginine-specific single-adenosine diphosphate ribosylation and the suppression of the protein expression of integrin α7β1, FAK and PI3K and the secretion of uPA, leading to reduced invasion by HepG2 cells.

View Figures

View References

1	Di Girolamo M, Dani N, Stilla A and Corda D: Physiological relevance of the endogenous mono (ADP-ribosyl)ation of cellular proteins. FEBS J. 272:4565–4575. 2005.PubMed/NCBI
2	Corda D and Di Girolamo M: Functional aspects of protein mono-ADP-ribosylation. EMBO J. 22:1953–1958. 2003. View Article : Google Scholar : PubMed/NCBI
3	Zolkiewska A and Moss J: Processing of ADP-ribosylated integrin 7 in skeletal muscle myotubes. J Biol Chem. 270:9227–9233. 1995. View Article : Google Scholar : PubMed/NCBI
4	Friedrich M, Böhlig L, Kirschner RD, Engeland K and Hauschildt S: Identification of two regulatory binding sites which confer myotube specific expression of the mono-ADP-ribosyltransferase ART1 gene. BMC Mol Bio. 9:912008. View Article : Google Scholar : PubMed/NCBI
5	Zhao Z, Gruszczynska-Biegala J and Zolkiewska A: ADP-ribosylation of integrin alpha7 modulates the binding of integrin alpha7beta1 to laminin. Biochem J. 385:309–317. 2005. View Article : Google Scholar : PubMed/NCBI
6	Loesberg C, van Rooij H and Smets LA: Meta-iodobenzylguanidine (MIBG), a novel high-affinity substrate for cholera toxin that interferes with cellular mono (ADP-ribosylation). Biochim Biophys Acta. 1037:92–99. 1990. View Article : Google Scholar : PubMed/NCBI
7	Yau L, Litchie B and Zahradka P: MIBG, an inhibitor of arginine-dependent mono (ADP-ribosyl)ation, prevents differentiation of L6 skeletal myoblasts by inhibiting expression of myogenin and p21^cip1. Exp Cell Res. 301:320–330. 2004. View Article : Google Scholar : PubMed/NCBI
8	Song Gl, Tang Y, Wang YL, Xu JX and Xiong W: Effect of ART 1 gene silencing on metastatic potential of mouse colon cancer CT26 cells and its mechanism. Tumor. 33:490–496. 2013.
9	Garaventa A, Gambini C, Villavecchia G, et al: Second malignancies in children with neuroblastoma after combined treatment with ¹³¹I-metaiodobenzylguanidine. Cancer. 97:1332–1338. 2003. View Article : Google Scholar : PubMed/NCBI
10	Shapiro B: Summary, conclusions, and future directions of [¹³¹I] metaiodobenzylguanidine therapy in the treatment of neural crest tumors. J Nucl Biol Med. 35:357–363. 1990.
11	Rathinam R and Alahari SK: Important role of integrins in the cancer biology. Cancer Metastasis Rev. 29:223–237. 2010. View Article : Google Scholar : PubMed/NCBI
12	Nishiuchi R, Takagi J, Hayashi M, et al: Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix Biol. 25:189–197. 2006. View Article : Google Scholar
13	Yao CC, Ziober BL, Squillace RM and Kramer RH: α7 integrin mediates cell adhesion and migration on specific laminin isoforms. J Biol Chem. 271:25598–25603. 1996.
14	Crawley S, Farrell EM, Wang W, et al: The α7β1 integrin mediates adhesion and migration of skeletal myoblasts on laminin. Exp Cell Res. 235:274–286. 1997.
15	Tsurumura T, Tsumori Y, Qiu H, et al: Arginine ADP-ribosylation mechanism based on structural snapshots of iota-toxin and actin complex. Proc Natl Acad Sci USA. 110:4267–4272. 2013. View Article : Google Scholar : PubMed/NCBI
16	Zolkiewska A: Ecto-ADP-ribose transferases: cell-surface response to local tissue injury. Physiology. 20:374–381. 2005. View Article : Google Scholar : PubMed/NCBI
17	Koistinen P and Heino J: Integrins in cancer cell invasion Cell invasion. Landes Bioscience; 2002
18	Prasadam I, Farnaghi S, Feng JQ, et al: Impact of extracellular matrix derived from osteoarthritis subchondral bone osteoblasts on osteocytes: role of integrinβ1 and focal adhesion kinase signaling cues. Arthritis Res Ther. 15:R1502013.PubMed/NCBI
19	Lim ST, Chen XL, Lim Y, et al: Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell. 29:9–22. 2008. View Article : Google Scholar : PubMed/NCBI
20	Schaller MD: Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta. 1540:1–21. 2001. View Article : Google Scholar : PubMed/NCBI
21	Zhao J and Guan JL: Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev. 28:35–49. 2009. View Article : Google Scholar : PubMed/NCBI
22	Thamilselvan V, Craig DH and Basson MD: FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway. FASEB J. 21:1730–1741. 2007. View Article : Google Scholar : PubMed/NCBI
23	Shen TL and Guan JL: Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts. FEBS Lett. 499:176–181. 2001. View Article : Google Scholar : PubMed/NCBI
24	Xia H, Nho RS, Kahm J, Kleidon J and Henke CA: Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a β1 integrin viability signaling pathway. J Biol Chem. 279:33024–33034. 2004.PubMed/NCBI
25	Chandrasekar N, Mohanam S, Gujrati M, Olivero WC, Dinh DH and Rao JS: Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene. 22:392–400. 2003. View Article : Google Scholar : PubMed/NCBI
26	Nowicki TS, Zhao H, Darzynkiewicz Z, et al: Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells. Cell Cycle. 10:100–107. 2011. View Article : Google Scholar
27	Shukla S, MacLennan GT, Hartman DJ, Fu P, Resnick MI and Gupta S: Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int J Cancer. 121:1424–1432. 2007. View Article : Google Scholar : PubMed/NCBI
28	Kargiotis O, Chetty C, Gogineni V, et al: uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo. Int J Oncol. 33:937–947. 2008.PubMed/NCBI
29	Dass K, Ahmad A, Azmi AS, Sarkar SH and Sarkar FH: Evolving role of uPA/uPAR system in human cancers. Cancer Treat Rev. 34:122–136. 2008. View Article : Google Scholar : PubMed/NCBI
30	Ulisse S, Baldini E, Sorrenti S and D’Armiento M: The urokinase plasminogen activator system: a target for anti-cancer therapy. Curr Cancer Drug Targets. 9:32–71. 2009. View Article : Google Scholar : PubMed/NCBI
31	Bevan P and Mala C: The role of uPA and uPA inhibitors in breast cancer. Breast Care. 3:1–2. 2008. View Article : Google Scholar : PubMed/NCBI
32	Chan CF, Yau TO, Jin DY, Wong CM, Fan ST and Ng IO: Evaluation of nuclear factor-κB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. Clin Cancer Res. 10:4140–4149. 2004.